More recently, the SUMMIT trial demonstrated that tirzepatide reduced the composite risk of cardiovascular death or worsening heart failure by 38% (HR = 0.62, 95% CI: 0.410.95) in patients with heart failure with preserved ejection fraction (HFpEF) and a BMI 30 kg/m 2 , 32% of whom also had type 2 diabetes
Fatty acid + ATP + CoA Acyl-CoA + PP i + AMP Table of the Mammalian Acyl-CoA Synthetase Family Fatty Acid Deactivation Once a fatty acid is esterified to coenzyme A forming an acyl-CoA, its fate is not destined for oxidation in the mitochondria or the peroxisomes
Advantages: D10W is less irritating to the veins than D50W
Its like your body is playing the hunger games against you
Small capillaries exist everywhere, and occasionally hitting one is unavoidable
Immune-mediated inflammatory disease therapeutics: past, present and future